The Benefit of Complete Response to Treatment in Patients With Chronic Spontaneous Urticaria—CURE Results - ScienceDirect
Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one‐year extension study - Maurer - 2022 - Allergy - Wiley Online Library
The Benefit of Complete Response to Treatment in Patients With Chronic Spontaneous Urticaria—CURE Results - ScienceDirect
PDF) Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one‐year extension study
Antihistamine‐resistant chronic spontaneous urticaria remains undertreated: 2‐year data from the AWARE study - Maurer - 2020 - Clinical & Experimental Allergy - Wiley Online Library